Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery.
Journal: JAMA network open
Published: May 21, 2026
Variations and patterns in germline and somatic testing by age in ovarian, primary peritoneal, and fallopian tube cancer patients: a descriptive analysis in a large, real-world clinical and genetic data registry.
Journal: Gynecologic oncology reports
Published: March 03, 2026
Molecular and spatial differences in the tumor microenvironment of high-grade serous ovarian cancers with short versus long-term survival.
Journal: Gynecologic oncology
Published: January 05, 2026
Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263).
Journal: Gynecologic oncology
Published: August 11, 2025
Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Journal: Future oncology (London, England)
Published: June 12, 2025
Mirvetuximab soravtansine in the ovarian cancer treatment landscape: influence of prior taxane exposure on outcomes.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 01, 2025
Current opinions: updates on the changing landscape in the management of cervical cancer.
Journal: Current opinion in obstetrics & gynecology
Published: December 26, 2024
Association of Physician Densities and Gynecologic Cancer Outcomes in the United States.
Journal: Obstetrics and gynecology
Published: April 24, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026